NovoCure Ltd.

19 clinical trials · Sponsor

Record	Firm	Date
TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France) (NCT06924099)	NovoCure Ltd.	2024-01-11
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma (NCT06390059)	NovoCure Ltd.	2023-08-28
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study (NCT05538806)	NovoCure Ltd.	2023-08-01
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study (NCT04717739)	NovoCure Ltd.	2021-12-30
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM (NCT04471844)	NovoCure Ltd.	2020-12-08
Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma (NCT04281576)	NovoCure Ltd.	2019-12-19
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) (NCT03940196)	NovoCure Ltd.	2019-03-22
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) (NCT03377491)	NovoCure Ltd.	2018-05-10

Every clearance here is in the API, with alerts when new ones post.